![](/img/cover-not-exists.png)
R26Phospho-mTOR expression levels, proliferative acitivity (Ki67) and pancreatic primary tumor may influence the response to everolimus in neuroendocrine tumor patients: results from an Italian preliminary study
Birocco, N., Brizzi, M.P., Airoldi, M., De Angelis, C., Maletta, F., Piovesan, A., Rapa, I., Sapino, A., Scaldaferri, M., Scagliotti, G., Papotti, M., Volante, M.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv348.26
Date:
October, 2015
File:
PDF, 30 KB
english, 2015